Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) management systems comprise a complex network of enzymatic and non-enzymatic components dedicated to maintaining cellular redox homeostasis (Sies et al., 2017, Nature Reviews Molecular Cell Biology). Key enzymatic players include superoxide dismutase (SOD), catalase, and glutathione peroxidase, while non-enzymatic components include glutathione and various dietary antioxidants (Hamanaka & Chandel, 2010, Science). These systems are critical for neutralizing excess ROS, which can cause oxidative damage to DNA, proteins, and lipids, leading to cellular dysfunction and death (Finkel, 2011, Nature). In many diseases, such as cancer and neurodegeneration, these systems are either overwhelmed or hijacked; for instance, cancer cells often upregulate ROS management to survive high metabolic stress and evade apoptosis (Gorrini et al., 2013, Nature Reviews Drug Discovery). Therapeutic strategies involve either augmenting these systems using Nrf2 activators or SOD mimetics to protect healthy tissue, or inhibiting them in cancer cells to induce ROS-mediated cytotoxicity (Trachootham et al., 2009, Nature Reviews Drug Discovery). However, targeting these systems is challenging due to the dual role of ROS as both damaging agents and essential signaling molecules, leading to the so-called antioxidant paradox where supplementation may sometimes worsen outcomes (Halliwell, 2011, British Journal of Pharmacology).
Modulation of cellular redox balance through the activation of antioxidant transcription factors, direct scavenging of free radicals, or enzymatic mimicry of endogenous antioxidant proteins.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species management systems (ROS management systems) (ROS management systems).